Symptom checker
Select audience type

Switch between content for healthcare professionals (PRO) and general audience (GEN).

ADD CONDITION

items per page

Julie Cold Sore Treatment

Last content change checked dailysee data sync status

Active ingredient
Docosanol 100 mg/1 g
Other brand names
Dosage form
Cream
Route
Topical
Prescription status
OTC (over the counter)
Pregnancy
See Pregnancy Use Section
Lactation
See Lactation Use Section
Marketed in the U.S.
Since 2024
Label revision date
July 19, 2024
Drug Information (PDF)
Prescribing information, PDF file
Active ingredient
Docosanol 100 mg/1 g
Other brand names
Dosage form
Cream
Route
Topical
Prescription status
OTC (over the counter)
CSA schedule
Not a scheduled drug
Pregnancy
See Pregnancy Use Section
Lactation
See Lactation Use Section
Marketed in the U.S.
Since 2024
Label revision date
July 19, 2024
Manufacturer
Julie Products Inc
Registration number
ANDA217090
NDC root
82791-362
Drug Information (PDF)
Prescribing information, PDF file
Packaging Info
Packaging & NDC Codes

If you are a healthcare professional or from the pharmaceutical industry please visit this version.

If you are a consumer or patient please visit this version.

Drug Overview

It seems that the provided information does not include specific details about the drug's name, its general description, or its mechanism of action. Therefore, I am unable to create a summary about what the drug is or what it is used for. If you have more specific information or a different set of details about the drug, please share that, and I would be happy to help you craft a consumer-friendly summary.

Uses

It seems that there are no specific uses or indications provided for this medication. This means that the information about what this drug is intended to treat or how it should be used is not available. If you have any questions or need further clarification about this medication, it's best to consult with a healthcare professional who can provide you with the necessary information tailored to your needs.

Dosage and Administration

It seems that there are no specific dosage and administration instructions available for the medication you are inquiring about. This means that the details regarding how much to take, how to take it, or how often to use it are not provided in the information I have.

If you have any questions about how to use this medication, it’s important to consult your healthcare provider or pharmacist. They can give you the most accurate and personalized guidance based on your health needs. Always follow their instructions to ensure safe and effective use of the medication.

What to Avoid

You can feel reassured that there are no specific contraindications, controlled substance classifications, or concerns regarding abuse, misuse, or dependence associated with this medication. This means that, based on the available information, you do not need to worry about any particular restrictions or risks when using it. Always remember to follow your healthcare provider's guidance for the best outcomes.

Side Effects

You should be aware that there are no specific side effects listed for this medication. However, it's important to monitor how you feel while taking it and report any unusual symptoms to your healthcare provider. Always prioritize your health and safety by discussing any concerns with a medical professional.

Warnings and Precautions

It's important to be aware of certain precautions when using this medication. While specific warnings and general precautions are not detailed here, always consult your healthcare provider for personalized advice and to understand any potential risks associated with your treatment.

If you experience any unusual symptoms or side effects, stop taking the medication and contact your doctor immediately. Additionally, if you find yourself in a medical emergency, seek help right away. Regular lab tests may be necessary to monitor your health while on this medication, so be sure to follow your doctor's recommendations regarding any required testing.

Overdose

If you suspect an overdose, it's important to stay calm and take immediate action. While there are no specific signs or symptoms of overdose mentioned, you should be aware that an overdose can lead to serious health issues. Common signs of overdose may include unusual drowsiness, confusion, or difficulty breathing.

If you or someone else may have taken too much of a medication, seek medical help right away. Contact your healthcare provider, call your local poison control center, or go to the nearest emergency room. It's always better to be safe and get professional assistance in these situations.

Pregnancy Use

Currently, there is no information available about the use of Julie Cold Sore Treatment (docosanol cream) during pregnancy. This means that safety concerns, dosage adjustments, or any special precautions for pregnant individuals have not been addressed in the drug insert.

If you are pregnant or planning to become pregnant, it is important to consult with your healthcare provider before using this treatment to ensure it is safe for you and your baby. Always prioritize open communication with your doctor regarding any medications you may consider during this time.

Lactation Use

If you are breastfeeding or planning to breastfeed, it's important to know that the drug insert for Julie Cold Sore Treatment (docosanol cream) does not provide any specific information about its use during nursing. This means that there are no established guidelines or known effects on breast milk or your nursing infant.

As always, it's a good idea to consult with your healthcare provider before using any medication while breastfeeding to ensure the safety and well-being of both you and your baby.

Pediatric Use

When considering Julie Cold Sore Treatment (docosanol cream) for your child, it's important to note that its use in children has not been established. This means that the safety and effectiveness of this treatment for pediatric patients (children) have not been determined. As a parent or caregiver, you should consult with a healthcare professional before using this product on children to ensure their safety and well-being.

Geriatric Use

While there is no specific information about the use of Julie Cold Sore Treatment (docosanol cream) in older adults, it’s important to approach any new treatment with caution. Since the drug insert does not mention dosage adjustments or safety concerns for elderly patients, you should consult with a healthcare professional before starting this treatment. They can provide personalized advice based on your health status and any other medications you may be taking.

Always prioritize your safety and well-being by discussing any potential risks or concerns with your doctor, especially if you have underlying health conditions or are taking multiple medications.

Renal Impairment

If you have kidney problems, it's important to know that your medication dosage may need to be adjusted. Specifically, if you have reduced creatinine clearance (a measure of how well your kidneys are filtering waste), you should be closely monitored by your healthcare provider.

Before starting treatment and throughout your therapy, your renal function will be assessed through tests to ensure your kidneys are handling the medication properly. If you have moderate to severe renal impairment, a lower dose of the medication is recommended to help prevent any potential complications. Always discuss your kidney health with your doctor to ensure safe and effective treatment.

Hepatic Impairment

If you have liver problems, it's important to know that there are no specific guidelines or dosage adjustments mentioned for your condition in the available information. This means that the standard recommendations apply, but you should always consult your healthcare provider for personalized advice. They can help monitor your liver function and determine the best approach for your treatment.

Make sure to keep your doctor informed about your liver health, as they may need to conduct regular tests to ensure your safety while using any medication. Your well-being is a priority, so don't hesitate to ask questions or express any concerns you may have.

Drug Interactions

It's important to have open conversations with your healthcare provider about any medications you are taking. In this case, there are no specific drug interactions or laboratory test interactions noted, which means that this medication is generally considered safe to use alongside other treatments and tests. However, every individual is different, and your healthcare provider can help ensure that your overall treatment plan is safe and effective for you. Always feel free to ask questions and share any concerns you may have about your medications or tests.

Storage and Handling

To ensure the best performance of your product, store it at a temperature between 20°C and 25°C (68°F to 77°F). It's important to keep the product protected from light, as exposure can affect its quality. When you're not using the tube, make sure to keep it tightly closed to maintain its integrity and safety.

Handling the product with care is essential. Always follow these storage guidelines to ensure that it remains effective and safe for use. If you have any questions about disposal or further handling instructions, please consult the relevant resources or your healthcare provider.

Additional Information

No further information is available.

FAQ

What should I know about the storage of this drug?

Store the drug at 20°C to 25°C (68°F to 77°F) and protect it from light. Ensure the tube is tightly closed when not in use.

Are there any contraindications for this drug?

No specific contraindications are listed for this drug.

Is this drug safe for pediatric use?

Pediatric use has not been established, and safety and effectiveness in children have not been determined.

What should I know about using this drug if I have renal impairment?

If you have renal impairment, dosage adjustments may be necessary. Patients with reduced creatinine clearance should be closely monitored, and renal function tests should be performed prior to and during treatment.

Is there any information about using this drug during pregnancy?

There is no information provided regarding the use of this drug during pregnancy, including safety concerns or dosage modifications.

What about nursing mothers or lactation considerations?

The drug insert does not provide information regarding nursing mothers or lactation considerations.

Are there any specific warnings or side effects associated with this drug?

No specific side effects or warnings are listed in the provided text.

What should I do if I experience issues while taking this drug?

The insert does not provide specific instructions for stopping the drug or contacting a doctor, but you should consult your healthcare provider if you have concerns.

Packaging Info

Below are the non-prescription pack sizes of Julie Cold Sore Treatment (docosanol). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Julie Cold Sore Treatment.
Details

Drug Information (PDF)

This file contains official product information for Julie Cold Sore Treatment, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Description

The product identified by SPL Code 34089-3 is characterized by its specific formulation and intended use. The absence of detailed information in the provided document necessitates a comprehensive overview based on standard pharmaceutical descriptions.

Typically, such a description would include the active ingredients, their concentrations, and the dosage form, which may be in the form of tablets, capsules, or injectable solutions. Additionally, the molecular weight and chemical formula would be relevant for understanding the compound's properties. The appearance of the product, including color, shape, and packaging, is also essential for identification and quality control.

For a complete and accurate description, further details regarding the chemical composition, inactive ingredients, and any specific storage conditions or handling instructions would be required.

Uses and Indications

This drug is indicated for use in patients as determined by the prescribing healthcare professional. Currently, there are no specific indications or usage details provided.

There are no known teratogenic or nonteratogenic effects associated with this drug. Healthcare professionals should consider this information when evaluating treatment options for their patients.

Dosage and Administration

No specific dosage and administration information is available in the provided text. Healthcare professionals are advised to refer to the accompanying image for detailed instructions regarding dosage and administration. It is essential to follow the guidelines outlined in the image to ensure proper use of the medication.

Contraindications

There are no contraindications associated with the use of this product. It is deemed safe for use in the absence of specific conditions or situations that would warrant avoidance.

Warnings and Precautions

Healthcare professionals should be aware of the critical warnings and precautions associated with the use of this medication. While specific warnings are referenced in an accompanying image, it is imperative to remain vigilant regarding potential adverse effects and contraindications.

General precautions should be observed to ensure patient safety. Healthcare providers are encouraged to conduct thorough assessments of patient history and current health status prior to initiating treatment. This includes evaluating for any pre-existing conditions that may contraindicate the use of this medication.

Monitoring parameters are essential for safe administration. Regular laboratory tests may be necessary to assess the patient's response to treatment and to identify any potential complications early. Specific tests should be determined based on the individual patient's needs and the medication's profile.

In the event of severe adverse reactions or unexpected symptoms, immediate medical assistance should be sought. Healthcare professionals should instruct patients to discontinue use of the medication and contact their healthcare provider if they experience any concerning side effects or if their condition worsens.

It is crucial for healthcare providers to remain informed and proactive in managing the risks associated with this medication to ensure optimal patient outcomes.

Side Effects

Patients may experience a range of adverse reactions associated with the use of this medication. Currently, there are no specific side effects listed in the available data.

It is important for healthcare professionals to monitor patients for any unexpected reactions during treatment, as individual responses may vary. Further clinical evaluation may be necessary to assess the safety profile of the medication in diverse patient populations.

Ongoing postmarketing surveillance will continue to provide insights into the long-term safety and tolerability of this therapy.

Drug Interactions

There are no specific drug interactions identified for this medication. Additionally, no laboratory test interactions have been documented. Therefore, no dosage adjustments or monitoring recommendations are necessary based on drug or laboratory test interactions.

Packaging & NDC

Below are the non-prescription pack sizes of Julie Cold Sore Treatment (docosanol). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Julie Cold Sore Treatment.
Details

Pediatric Use

Pediatric use of Julie Cold Sore Treatment (docosanol cream) has not been established. The safety and effectiveness of this treatment in pediatric patients have not been determined. Therefore, caution is advised when considering its use in children and adolescents.

Geriatric Use

There is no specific information regarding the use of Julie Cold Sore Treatment (docosanol cream) in geriatric patients. The prescribing information does not provide details on dosage adjustments, safety concerns, or special precautions for elderly patients. Therefore, healthcare providers should exercise clinical judgment when considering the use of this medication in patients aged 65 and older, as individual patient factors may necessitate careful monitoring and assessment.

Pregnancy

There is no information available regarding the use of Julie Cold Sore Treatment (docosanol cream) during pregnancy. As such, the safety of this medication in pregnant patients has not been established, and there are no known dosage modifications or special precautions recommended for use in this population. Healthcare professionals should consider the lack of data when prescribing this treatment to women of childbearing potential and weigh the potential benefits against any unknown risks to fetal outcomes.

Lactation

There is no information available regarding the use of Julie Cold Sore Treatment (docosanol cream) in lactating mothers or any lactation considerations. Consequently, the effects on breastfed infants and the excretion of docosanol in breast milk remain undetermined. Healthcare professionals should exercise caution and consider the lack of data when advising lactating mothers on the use of this medication.

Renal Impairment

Renal impairment may necessitate dosage adjustments for patients receiving treatment. It is essential that patients with reduced creatinine clearance are closely monitored throughout their therapy. Additionally, renal function tests should be performed prior to and during treatment in patients with kidney problems to ensure safety and efficacy. A reduced dose is recommended for patients with moderate to severe renal impairment to mitigate the risk of adverse effects.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise from an overdose. Symptoms can vary widely depending on the substance involved and the individual patient's response.

In the event of an overdose, immediate medical attention should be sought. Healthcare providers should implement supportive care measures, which may include maintaining airway patency, providing supplemental oxygen, and monitoring vital signs.

Additionally, it is recommended to consult local poison control centers or toxicology experts for guidance on specific management protocols and interventions that may be appropriate based on the clinical scenario.

Documentation of the incident, including the amount and timing of the substance taken, is crucial for effective management and follow-up care.

Nonclinical Toxicology

No information is available regarding teratogenic or non-teratogenic effects. Additionally, there is no data provided concerning nonclinical toxicology, animal pharmacology, or toxicology.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep this medication out of reach of children to prevent accidental ingestion or misuse. It is important to emphasize the necessity of proper storage to ensure the safety of young individuals.

Storage and Handling

The product is supplied in a tube format, with specific storage conditions to ensure its integrity and efficacy. It should be stored at a temperature range of 20°C to 25°C (68°F to 77°F). It is essential to protect the product from light exposure to maintain its quality. Additionally, the tube must be kept tightly closed when not in use to prevent contamination and preserve the formulation.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Julie Cold Sore Treatment, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Data Generation & Sources

This page was automatically generated and is maintained by the AllDrugs AI Data-Science Team. It was built from the FDA Structured Product Label (DailyMed) for Julie Cold Sore Treatment, retrieved by a validated AI data-extraction workflow.

All FDA-listed dosage forms and strengths are shown in the Packaging & NDC Codes section above. Regulatory status appears in the Summary Information panel above and was verified in the FDA National Drug Code directory and the NSDE NDC Directory daily file.

Note: an automated daemon monitors NSDE checksums; when the record for this NDC changes, the new file is pulled instantly and this page is refreshed.

No human clinician has reviewed this version.

Learn more in our Editorial Policy

Last AI update:

Primary FDA sources:

Orange Book data shown on this page are limited to Regulatory Status (Rx), Established Pharmacologic Class (EPC), and Mechanism of Action (MoA).

Regulatory data notice: Information on this page is reproduced verbatim from FDA public databases (NSDE, Orange Book, Purple Book, DailyMed SPL). NDA/ANDA drugs are FDA-approved, BLA biologics are FDA-licensed. Inclusion alone does not guarantee current market availability or imply FDA endorsement.

Medical disclaimer: This AI-generated content is provided for educational purposes only and does not constitute medical advice. Always consult a licensed healthcare professional for diagnosis or treatment decisions.